VIVA BIOTECH
Viva Biotech offers global innovative drug R&D companies one-stop comprehensive services ranging from early structure-based drug R&D to commercial drug delivery. Using its advantages in the field of structure-based drug discovery (SBDD) technology, it provides global partners with CRO services in the new drug research stage and has established X-ray protein crystal technology, cryo-electron microscopy (Cryo-EM), and affinity mass spectrometry screening technology (ASMS), surface plasmon resonance (SPR), hydrogen-deuterium exchange mass spectrometry (HDX-MS), computer-aided drug design, and other advanced technology platforms.
VIVA BIOTECH
Industry:
Clinical Trials Health Care Medical
Founded:
2008-01-01
Status:
Active
Contact:
+86(0)21 6089 3288
Email Addresses:
[email protected]
Total Funding:
247.46 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager SSL By Default Mobile Non Scaleable Content IPv6 PHP DigiCert SSL Encryption Everywhere
Similar Organizations
Motherhood India
Motherhood India is a healthcare startup.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Ringpai National Chain Veterinary Hospital
Tianjin Based is a Healthcare Start Up based in Tianjin.
SinoUnited Health Clinic
A health clinic based in Shinghai,China.
Sumgen Biotech
Sumgen Biotech is a Healthcare Start Up Based in Hangzhou.
Current Employees Featured
Founder
Stock Details
Investors List
Temasek Holdings
Temasek Holdings investment in Post-IPO Equity - Viva Biotech
TrueLight Capital
TrueLight Capital investment in Post-IPO Equity - Viva Biotech
Highlight Capital
Highlight Capital investment in Post-IPO Equity - Viva Biotech
Xiamen Changrong Investment Management
Xiamen Changrong Investment Management investment in Venture Round - Viva Biotech
Beida Biomedical Industry Fund
Beida Biomedical Industry Fund investment in Venture Round - Viva Biotech
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund investment in Venture Round - Viva Biotech
JMCR Partners
JMCR Partners investment in Venture Round - Viva Biotech
Yingqi Investment
Yingqi Investment investment in Venture Round - Viva Biotech
Ming Bioventures
Ming Bioventures investment in Venture Round - Viva Biotech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-14 | Eubulus | Viva Biotech investment in Series A - Eubulus | 10 M USD |
| 2020-09-10 | Totient | Viva Biotech investment in Seed Round - Totient | 10 M USD |
| 2020-08-27 | Triumvira Immunologics | Viva Biotech investment in Series A - Triumvira Immunologics | 55 M USD |
| 2020-03-25 | Regenacy Pharmaceuticals | Viva Biotech investment in Series A - Regenacy Pharmaceuticals | N/A |
| 2020-01-06 | DTx Pharma | Viva Biotech investment in Series A - DTx Pharma | 10.6 M USD |
| 2019-11-08 | AcuraStem | Viva Biotech investment in Convertible Note - AcuraStem | 1000 K USD |
| 2019-10-14 | Mebias Discovery | Viva Biotech investment in Venture Round - Mebias Discovery | 3.5 M USD |
More informations about "Viva Biotech"
Viva Biotech
With its leading position in Structure-Based Drug Discovery (SBDD), Viva provides state-of-the-art drug research and development services to global biotechnology and pharmaceutical …See details»
About Us - Viva Biotech
Dec 31, 2021 · With its leading position in Structure-Based Drug Discovery (SBDD), Viva provides state-of-the-art drug research and development services to global biotechnology and …See details»
The Interview of Cheney Mao, Chairman & CEO of Viva …
Dr Cheney Mao, chairman and CEO of Viva Biotech, shares the extremely unique business model of the company, which started as a highly specialized CRO in 2008, before launching a new ‘equity-for-service’ model in 2016 that focused …See details»
Viva Ventures Biotech I 维亚生物
May 23, 2022 · Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial drug delivery to global biopharmaceutical innovators.See details»
Viva Biotech - Crunchbase Investor Profile & Investments
Viva Biotech is a Healthcare Start Up Based In Shanghai. View contacts for Viva Biotech to access new leads and connect with decision-makers. Viva Biotech offers global innovative …See details»
Entrepreneurial Company of the Year - Frost & Sullivan
Founded in 2008 as a highly specialized contract research organization (CRO), Viva Biotech delivered in the first half of 2020 more than 17,000 protein complex structures and investigated …See details»
Corporate Governance - Investor Relations - Viva Biotech
By 2024-11-20 02:20:51 More than 15 minutes delay in quotation. Corporate Governance. Corporate governanceSee details»
Viva Biotech Announced Strategic Investors with an ... - BioSpace
On June 11, 2023, Viva Biotech Holdings Group announced that Viva Shanghai, the primary entity for Viva Biotech's CRO business, successfully raised nearly US$ 150 million through the …See details»
Viva Biotech Revenues Surge On Move Into Contract Drug …
Sep 9, 2021 · Viva Biotech’s fivefold jump in first-half revenues and move back to profitability come on the back of its acquisition last year of two contract drug makers. Company’s shift to …See details»
Viva Biotech - Drug R&D Services
Viva provides state-of-the-art drug research and development services to global biotechnology and pharmaceutical clients for their preclinical, innovative drug discovery programs. From …See details»
China's Viva Biotech snaps up Hong Kong CRO …
Sep 23, 2020 · Viva Biotech is putting down $80 million to buy preclinical contract research organization SYNthesis and boost its outsourcing business.See details»
Viva Biotech Revenues Surge on Move Into Contract Drug
Sep 11, 2021 · Viva Biotech’s revenue surged more than fivefold in the first half of this year to 1.03 billion yuan ($159.4 million) from the year-ago period, according to its latest report …See details»
Viva Biotech Announced 2022 Annual Results
As of December 31, 2022, Viva Biotech has provided drug R&D and production services to 2,076 biotech and pharmaceutical clients around the world. We have invested and incubated 91 …See details»
Viva Biotech | Company Overview & News - Forbes
The firm provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development. The company was...See details»
Viva Biotech Announces 2021 Annual Results - Viva BioInnovator
As of December31, 2021, Viva Biotech has provided drug R&D and production services to1,820 biotech and pharmaceutical clients around the world. We have invested and incubated 87 …See details»
Viva Biotech and Langhua Pharmaceutical Reached the Strategic ...
Aug 10, 2020 · Viva Biotech operates a leading structure-based, integrated drug discovery platform, providing drug discovery services to biotechnology and pharmaceutical customers …See details»
Company News - Viva Biotech
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology PlatformsSee details»
Viva Biotech and Langhua Pharmaceutical Reached the ... - BioSpace
On August 9th, 2020, Viva Biotech Co., Ltd. entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 80% of the …See details»
Viva Biotech Enters Strategic Collaboration with Biocytogen
Shanghai and Beijing - Viva Biotech (Shanghai) Co., Ltd. ("Viva Biotech") and Bejing Biocytogen Co., Ltd. (“Biocytogen”) and announced today a strategic collaboration to jointly accelerate the …See details»
CRO Services-CRO Services-Viva Biotech
We are committed to providing global pharmaceutical and biotechnology companies with one-stop discovery biology services from target protein preparation to PCC identification.See details»